메뉴 건너뛰기




Volumn 7, Issue 16, 2001, Pages 1689-1701

License to kill tumors: How much hope is justified for trail?

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTINEOPLASTIC AGENT; APOPTOSIS INDUCING FACTOR; BINDING PROTEIN; CACHEXIN; CASPASE 8; COMPLEMENTARY DNA; CYTOKINE; CYTOTOXIC AGENT; DACTINOMYCIN; DNA FRAGMENT; DOXORUBICIN; ETOPOSIDE; FAS LIGAND; FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; METHYLTRANSFERASE INHIBITOR; NEW DRUG; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 0034777736     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612013397212     Document Type: Article
Times cited : (9)

References (136)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.